vincamine has been researched along with Diabetes Mellitus, Adult-Onset in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Du, T; Hu, L; Liu, X; Lv, X; Shen, X; Sun, G; Wang, J; Xu, J | 1 |
| Chen, J; Du, T; Hu, L; Huang, X; Lu, J; Lv, J; Shen, X; Shi, X; Wang, H; Xu, X; Yang, L; Ye, J | 1 |
2 other study(ies) available for vincamine and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Design, synthesis and biological evaluation of vincamine derivatives as potential pancreatic β-cells protective agents for the treatment of type 2 diabetes mellitus.
Topics: Animals; Cells, Cultured; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Design; Hypoglycemic Agents; Insulin-Secreting Cells; Molecular Structure; Protective Agents; Rats; Structure-Activity Relationship; Vincamine | 2020 |
Vincamine as a GPR40 agonist improves glucose homeostasis in type 2 diabetic mice.
Topics: Animals; Blood Glucose; Cell Line, Tumor; Cell Proliferation; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucose; Homeostasis; Insulin Secretion; Insulin-Secreting Cells; Male; Mice; Receptors, G-Protein-Coupled; Signal Transduction; Vasodilator Agents; Vincamine | 2019 |